Biopharma investor relations
WebContact. 225 Long Avenue, Hillside, NJ 07205 USA Tel 973.926.0816 Fax 973.926.1735. Investor Relations Tel 888.319.6962 Web2 days ago · DUBLIN, April 11, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (" Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the appointment of Jim Kelly, Managing Director at Weiss Asset Management, the Company's second largest shareholder, to its Board of Directors.With the appointment of Mr. Kelly, …
Biopharma investor relations
Did you know?
WebStatera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. Statera has a large platform of toll-like ... WebPOINT Biopharma Announces Closing of Agreements with Lantheus Holdings. POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been …
WebApr 12, 2024 · Displaying 1 - 10 of 869 results. Data provided by Kaleidoscope. For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc. http://biopharmacapital.com/
WebThe Investor Relations website contains information about Landos Biopharma's business for stockholders, potential investors, and financial analysts. ... Landos Biopharma is a … Web1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor …
WebApr 3, 2024 · Company Overview. Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial …
WebAbout CTI BioPharma Corp. We are a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related … di chuyen thu muc onedriveWebSep 30, 2024 · INVESTOR RELATIONS KEY FIGURES. Kedrion is a leading biopharmaceutical company that specializes in the development, production and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as immune system deficiencies and coagulation disorders. citizen newspaper phenix city alWebMar 14, 2024 · Investor Relations Company Profile. YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and … citizen newspaper key west flWebNov 10, 2024 · Benitec Biopharma Inc. is a development-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, … citizen news tonightWebMar 16, 2024 · Investor Relations. Arbutus Biopharma Corporation ( NASDAQ:ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to … dich vu cai win online tu xaWebTheravance Biopharma is a biopharmaceutical company with one approved product that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with … dich vu cham soc fanpageWebApr 10, 2024 · Corporate Overview. RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies … dichvucong baohiemyte